Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.53 |
| ▸ | PNP | P00491 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.34 |
| ▸ | HSPA8 | P11142 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26079955 | 0.85 | MEN1 (0.71) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL23202083 | 0.85 | MEN1 (0.71) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL10117778 | 0.85 | MEN1 (0.71) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL455853 | 0.85 | MEN1 (0.71) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL114650 | 0.80 | LMNA (0.45) | PNPMAPTGMNNALDH1A1LMNA | |
| SCHEMBL6448926 | 0.77 | PNP (0.66) | MEN1KMT2ATLR7PNPCYP3A4 | |
| Phosphoric Acid SCHEMBL20305093 | 0.77 | LMNA (0.42) | PNPMAPTGMNNALDH1A1LMNA | |
| SCHEMBL28692399 | 0.77 | MEN1 (0.72) | MEN1KMT2ATLR7PNPCYP3A4 | |
| Phosphoric Acid SCHEMBL6465085 | 0.77 | LMNA (0.42) | PNPMAPTGMNNALDH1A1LMNA | |
| Deoxyguanosine SCHEMBL29106456 | 0.75 | POLB (0.51) | PNPLMNATP53DNMT1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11866754-B2 | Trinucleotide mRNA cap analogs | MODERNATX, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| US-20190211368-A1 | TRINUCLEOTIDE MRNA CAP ANALOGS | MODERNATX, INC. | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211368-A1 | TRINUCLEOTIDE MRNA CAP ANALOGS | RNGTT, RNMT, CPSF7 | MEN1 4726/4885KMT2A 2782/4885TLR7 2428/4885 |
| US-11866754-B2 | Trinucleotide mRNA cap analogs | RNGTT, RNMT, CPSF7 | MEN1 4726/4885KMT2A 2782/4885TLR7 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.